{
  "id": "dominant-negative-mutation",
  "title": "Dominant-Negative Mutation",
  "lang": "en",
  "source_lang": "en",
  "summary": "A dominant-negative mutation produces a gene product that interferes with the normal product, reducing function even when a functional allele is present.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "Antimorphic mutation",
    "dominant-interfering mutation"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/dominant-negative-mutation/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/dominant-negative-mutation/",
      "json": "https://aiwiki.page/zh/dominant-negative-mutation.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "A dominant-negative mutation is a mutation whose product interferes with the function of the normal product of the same gene. Rather than simply failing to work, the altered product actively disrupts a molecular process in which the normal product participates. Consequently, a mutant allele can affect the phenotype even when a functional allele is present. Most well-characterized examples involve a mutant protein that retains the ability to bind normal proteins, assemble into complexes, or engage shared molecular partners, but cannot perform its normal role."
    },
    {
      "heading": "Genetic meaning and terminology",
      "text": "“Dominant” describes the relationship between alleles for a particular phenotype; it does not mean that the mutant allele is necessarily expressed more strongly than the normal allele. “Negative” refers to interference with normal function.\n\nDominant-negative mutations are traditionally called antimorphic mutations, a category in the functional classification of mutations developed by geneticist Hermann J. Muller in the early twentieth century. The term dominant negative became widely used in molecular biology, particularly for deliberately engineered proteins that inhibit their normal counterparts.\n\nA dominant-negative effect is a mechanism, not a universal property of a sequence change. Its strength can depend on relative gene expression, protein stability, cellular location, and the availability of interacting partners. The same variant may therefore have different effects in different tissues or experimental systems."
    },
    {
      "heading": "Molecular mechanisms",
      "text": "Disruption of multimeric complexes\n\nMany proteins function as dimers, trimers, tetramers, or larger assemblies. A mutant subunit may retain its assembly interface but lose another essential activity. If it joins normal subunits, the resulting mixed complex may work poorly or not at all.\n\nThis mechanism is especially effective when the activity of a complex requires coordinated action by all its subunits. A defective subunit can impair the entire assembly rather than merely contribute no activity of its own.\n\nExamples include some enzymes, ion channels, structural proteins, and transcription factors. However, formation of a mixed complex does not automatically establish dominant-negative action: some complexes tolerate defective subunits or retain partial function.\n\nSequestration of shared partners\n\nAn altered protein may bind a normal interaction partner without completing the next step in a process. By trapping a limiting partner in an inactive complex, it reduces that partner’s availability to the normal protein.\n\nThe trapped component may be a regulatory protein, a cofactor, or another required molecular partner. Direct binding between mutant and normal versions of the affected protein is therefore not essential to every dominant-negative mechanism.\n\nCompetition for binding sites\n\nA mutant protein may retain the ability to bind DNA, a receptor, or another target while losing the ability to produce the normal downstream response. Occupation of those sites can prevent productive binding by the normal protein.\n\nFor example, an altered transcription factor may bind its recognition sequence but fail to activate transcription. Whether this causes substantial interference depends on binding affinities, concentrations, and the organization of the regulatory system.\n\nDisruption of localization or assembly\n\nMutant proteins can also interfere by redirecting normal partners to an inappropriate cellular compartment, preventing their transport, or disturbing the formation of structural networks. Such effects occur in some proteins of the cytoskeleton and extracellular matrix.\n\nDefective protein folding alone does not establish a dominant-negative mechanism. The altered protein must interfere with normal function, rather than simply be degraded or cause unrelated cellular damage."
    },
    {
      "heading": "A quantitative model",
      "text": "A simple model illustrates why interference can produce a larger functional deficit than loss of one allele alone.\n\nSuppose that:\n\n- a functional complex contains \\(n\\) subunits;\n- the fraction of available subunits that are normal is \\(p\\);\n- subunits assemble independently and randomly;\n- a single mutant subunit completely inactivates a complex.\n\nThe fraction of complexes containing only normal subunits is then\n\n\\[P(\\text{functional complex}) = p^n.\\]\n\nIf normal and mutant subunits are equally abundant, \\(p = 1/2\\). The predicted functional fractions are therefore \\(1/4\\) for a dimer and \\(1/16\\) for a tetramer.\n\nThese values are illustrative, not general predictions for particular mutations. Real systems can depart from the model because mutant and normal proteins differ in stability, preferentially associate with particular partners, or form mixed complexes that retain activity. Cellular output also depends on the total number of complexes and on how much activity is required for normal function."
    },
    {
      "heading": "Distinction from other mutation mechanisms",
      "text": "Ordinary loss of function\n\nA loss-of-function mutation reduces or eliminates the activity of its own gene product. If one functional allele supplies enough activity, the resulting phenotype may be recessive.\n\nA dominant-negative product generally has reduced normal activity as well, but it additionally interferes with the product of the functional allele. This additional interference is the defining feature. A complete deletion that produces no interfering product ordinarily does not act through a dominant-negative mechanism.\n\nHaploinsufficiency\n\nIn haploinsufficiency, one functional copy of a gene does not supply enough product for a normal phenotype. No inhibitory mutant product is required.\n\nBoth mechanisms can produce dominant inheritance, but their molecular explanations differ:\n\nFeature | Haploinsufficiency | Dominant-negative effect\nMain defect | Insufficient functional gene product | Interference by an altered gene product\nMutant product required | No | Yes\nEffect of a nonexpressed allele | Can produce the phenotype | Does not itself supply an interfering product\nImportance of molecular interactions | Not necessarily central | Usually central\n\nA gene can have different variants that act through different mechanisms.\n\nGain of function and toxicity\n\nA gain-of-function mutation increases an activity, creates a new activity, or changes when or where an activity occurs. Dominant-negative mutations are often discussed separately because their characteristic effect is interference with normal function, although the interference itself can be regarded as an acquired molecular property.\n\nLikewise, a mutant protein that damages cells through aggregation or another toxic process is not necessarily dominant negative. Toxicity and dominant-negative interference can coexist, but one does not establish the other."
    },
    {
      "heading": "Biological examples",
      "text": "Collagen\n\nSome variants affecting type I collagen illustrate dominant-negative disruption of a structural protein. Type I collagen normally contains two α1(I) chains and one α2(I) chain assembled into a triple helix. Certain altered chains can enter this structure and impair its folding, stability, or incorporation into the extracellular matrix.\n\nSuch mechanisms occur in some forms of osteogenesis imperfecta. Other variants, including some that reduce production of an otherwise normal collagen chain, act through quantitative deficiency rather than the same dominant-negative mechanism. The consequences therefore depend on the particular variant and chain affected.\n\np53\n\nThe p53 protein is a transcription factor that functions as a tetramer. Some mutant forms retain the ability to assemble with normal p53 while impairing the activity of mixed complexes. These variants can consequently exert dominant-negative effects on normal p53.\n\nNot all p53 variants behave this way. Some primarily eliminate function, and some also display additional activities. Dominant-negative behavior depends on the variant and cellular context.\n\nKeratins and ion channels\n\nCertain keratin variants disrupt filament organization despite the presence of normal keratin proteins. Their incorporation into structural assemblies can impair the integrity of the larger network.\n\nSome multimeric ion channels likewise show dominant-negative effects when mutant subunits coassemble with normal subunits and impair channel trafficking or electrical function. The extent of interference depends on subunit composition and on whether mixed channels reach the cell membrane."
    },
    {
      "heading": "Experimental identification and uses",
      "text": "Dominant-negative proteins are widely used as experimental tools to inhibit selected molecular functions. A researcher may, for example, alter a catalytic site while preserving the interfaces needed for assembly or partner binding.\n\nEvidence for dominant-negative action commonly includes:\n\n- reduced activity when mutant and normal products are expressed together;\n- a stronger defect than that caused by a comparable reduction in normal gene dosage;\n- dependence on an interaction or assembly interface retained by the mutant;\n- formation of inactive mixed complexes or sequestration of an essential partner;\n- effects that vary with the ratio of mutant to normal product.\n\nNo single observation is sufficient in every system. In particular, inhibition caused by very high mutant-protein expression can reflect nonspecific interactions, cellular stress, or artificial depletion of shared partners. Experiments using genome editing at the endogenous gene can help distinguish physiological effects from overexpression artifacts.\n\nDominant-negative constructs also have limits as probes of gene function. They may inhibit related proteins that share interaction partners, and they may leave some functions of the targeted protein intact. Their effects therefore need not reproduce those of deleting the gene."
    },
    {
      "heading": "Interpretation of genetic variants",
      "text": "A dominant inheritance pattern alone does not demonstrate a dominant-negative mechanism. Similar inheritance patterns can result from haploinsufficiency, increased activity, altered specificity, or toxicity.\n\nMechanistic interpretation requires evidence about the particular variant: whether its product is expressed and stable, which interactions it retains, and how it changes normal molecular activity. Sequence location or computational prediction can suggest a hypothesis, but neither by itself demonstrates dominant-negative interference."
    }
  ],
  "links": [
    "mutation",
    "gene",
    "allele",
    "phenotype",
    "protein",
    "gene-expression",
    "enzyme",
    "ion-channel",
    "transcription-factor",
    "cofactor",
    "dna",
    "transcription-biology",
    "cytoskeleton",
    "protein-folding",
    "collagen",
    "osteogenesis-imperfecta",
    "cell-membrane",
    "genome-editing"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}